| REG-Biocompatibles Intl.: Statement re Positive Data in Combination Therapy Trial - Reuters |
|
|
ReutersTreatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable ... read more |